Market Cap 13.16M
Revenue (ttm) 0.00
Net Income (ttm) -9.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 74,900
Avg Vol 44,450
Day's Range N/A - N/A
Shares Out 7.19M
Stochastic %K 63%
Beta 0.51
Analysts Strong Sell
Price Target $15.00

Company Profile

Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major inflammatory and fibrotic pathways, which has completed phase 2 clinical trial for treating primary sclerosing cholangitis, as well as in phase 2 clinical trial to treat systemi...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 77 331 0156
Address:
Building C, 10th Floor 10 Habarzel Street, Tel Aviv-Yafo, Israel
W2Cap
W2Cap May. 13 at 2:29 PM
$CMMB how's everyone feeling about tomorrow? with the adjournment of the initial meeting a few weeks back, I'm hoping it was to finalise some kind of announcement or deal/partnership. Price movement has been good, yesterdays volume was promising; and a few decent volume days have been happening. Seen a lot of big early morning pumps to get over 2 dollars on low volume; anyone got data on call/put volume?
1 · Reply
dom3
dom3 May. 13 at 1:28 PM
$CMMB Well; lets see if we can get back to back volume for a change. Would be a welcome development.
0 · Reply
DLTT4489
DLTT4489 May. 12 at 9:00 PM
0 · Reply
dom3
dom3 May. 12 at 7:50 PM
$CMMB Excellent volume today compared to previous days. What we rarely see is a follow through on volume. Maybe wednesday.
0 · Reply
dom3
dom3 May. 12 at 3:14 PM
$CMMB its only 11 and volume is already higher than normal. This is what we want to see. AGAIN, 70-80 thousand share day would be nice.
0 · Reply
dom3
dom3 May. 12 at 2:02 PM
$CMMB Continues to look and feel good. Technicals matter but the fuse is a catalyst. The market always knows. If volume surges unexpectedly...then we will know.
0 · Reply
Zdxss1
Zdxss1 May. 12 at 1:24 PM
$CMMB The stock is like a powder keg — any spark will trigger an explosive move.
0 · Reply
Stockhunter008
Stockhunter008 May. 12 at 12:36 PM
$CMMB March deck on $CMMB web site is evidence of improved pitch to FDA BTD. 60 day response window is approaching. That plus May 14th "earnings" and end of May EASL conference bode well....
1 · Reply
DLTT4489
DLTT4489 May. 12 at 10:48 AM
$CMMB what happened to $2.12 fake pump?? Will be red as always. Short are the biiig winners here 👏 🤑🤑🤑😜😜😜
0 · Reply
DLTT4489
DLTT4489 May. 12 at 10:09 AM
$CMMB fake pump 😅😅😅
0 · Reply
Latest News on CMMB
Chemomab Therapeutics sees cash runway through 1Q27

2026-03-19T12:11:46.000Z - 7 weeks ago

Chemomab Therapeutics sees cash runway through 1Q27


Chemomab Therapeutics reports Q3 EPS (0.4c) vs (1c) last year

2025-11-20T13:05:27.000Z - 6 months ago

Chemomab Therapeutics reports Q3 EPS (0.4c) vs (1c) last year


Chemomab Therapeutics management to meet with Maxim

2025-09-12T16:55:11.000Z - 8 months ago

Chemomab Therapeutics management to meet with Maxim


Chemomab Therapeutics Ltd – ADR trading halted, news pending

2025-08-25T23:50:06.000Z - 9 months ago

Chemomab Therapeutics Ltd – ADR trading halted, news pending


Chemomab Therapeutics reports Q2 EPS 0.4c vs 0.013c last year

2025-08-14T12:11:23.000Z - 9 months ago

Chemomab Therapeutics reports Q2 EPS 0.4c vs 0.013c last year


Chemomab Therapeutics management to meet with Maxim

2025-07-31T17:55:26.000Z - 10 months ago

Chemomab Therapeutics management to meet with Maxim


Chemomab Announces New Medical and Clinical Appointments

Apr 15, 2025, 8:00 AM EDT - 1 year ago

Chemomab Announces New Medical and Clinical Appointments


Chemomab Therapeutics Transcript: Study Result

Jul 25, 2024, 8:00 AM EDT - 1 year ago

Chemomab Therapeutics Transcript: Study Result


Chemomab Therapeutics Announces $10 Million Private Placement

Jul 25, 2024, 7:38 AM EDT - 1 year ago

Chemomab Therapeutics Announces $10 Million Private Placement


Chemomab Therapeutics Transcript: KOL Event

Apr 10, 2024, 10:00 AM EDT - 2 years ago

Chemomab Therapeutics Transcript: KOL Event


W2Cap
W2Cap May. 13 at 2:29 PM
$CMMB how's everyone feeling about tomorrow? with the adjournment of the initial meeting a few weeks back, I'm hoping it was to finalise some kind of announcement or deal/partnership. Price movement has been good, yesterdays volume was promising; and a few decent volume days have been happening. Seen a lot of big early morning pumps to get over 2 dollars on low volume; anyone got data on call/put volume?
1 · Reply
dom3
dom3 May. 13 at 1:28 PM
$CMMB Well; lets see if we can get back to back volume for a change. Would be a welcome development.
0 · Reply
DLTT4489
DLTT4489 May. 12 at 9:00 PM
0 · Reply
dom3
dom3 May. 12 at 7:50 PM
$CMMB Excellent volume today compared to previous days. What we rarely see is a follow through on volume. Maybe wednesday.
0 · Reply
dom3
dom3 May. 12 at 3:14 PM
$CMMB its only 11 and volume is already higher than normal. This is what we want to see. AGAIN, 70-80 thousand share day would be nice.
0 · Reply
dom3
dom3 May. 12 at 2:02 PM
$CMMB Continues to look and feel good. Technicals matter but the fuse is a catalyst. The market always knows. If volume surges unexpectedly...then we will know.
0 · Reply
Zdxss1
Zdxss1 May. 12 at 1:24 PM
$CMMB The stock is like a powder keg — any spark will trigger an explosive move.
0 · Reply
Stockhunter008
Stockhunter008 May. 12 at 12:36 PM
$CMMB March deck on $CMMB web site is evidence of improved pitch to FDA BTD. 60 day response window is approaching. That plus May 14th "earnings" and end of May EASL conference bode well....
1 · Reply
DLTT4489
DLTT4489 May. 12 at 10:48 AM
$CMMB what happened to $2.12 fake pump?? Will be red as always. Short are the biiig winners here 👏 🤑🤑🤑😜😜😜
0 · Reply
DLTT4489
DLTT4489 May. 12 at 10:09 AM
$CMMB fake pump 😅😅😅
0 · Reply
W2Cap
W2Cap May. 12 at 9:02 AM
$CMMB all these trading levels mean nothing. - BTD news - Partnership news Get one or both and these levels become irrelevant.
2 · Reply
JoeShmoDoe
JoeShmoDoe May. 12 at 2:44 AM
0 · Reply
Zdxss1
Zdxss1 May. 11 at 8:18 PM
$CMMB One of the strongest signals is when, after shareholders approve the authorization and raise the share ceiling, the stock price rises instead of falling. Normally, markets fear dilution — so if the price holds or even climbs after such approval, it means investors believe management will use that flexibility strategically, not recklessly. This is a bullish technical and fundamental indicator. Price action: A rise post‑authorization shows demand outweighs dilution fears. It reflects accumulation and confidence in upcoming catalysts. • Strategic intent: Management gains flexibility without immediately issuing shares, which reassures investors that. Market psychology: Investors interpret the approval as a sign that management is preparing for growth, not survival financing.
1 · Reply
DLTT4489
DLTT4489 May. 11 at 6:12 PM
$CMMB watch out, big dump coming
2 · Reply
dom3
dom3 May. 11 at 5:08 PM
$CMMB Okay; the easy move from the bottom is complete. The chart needs to see a move thru 2 dollars now on better than average volume and we will hit next resistance in the 2.20 level in a flash.
0 · Reply
grumpygoose
grumpygoose May. 11 at 5:07 PM
$CMMB Signs of life Am I dreaming
0 · Reply
Snptrader
Snptrader May. 11 at 5:06 PM
$CMMB move through $2 should get an expansion in volume with a push to $2.24
0 · Reply
W2Cap
W2Cap May. 11 at 4:37 PM
$CMMB hope so. Some encouraging moves upwards even if on low volume. Here for a face ripping event though.
1 · Reply
Zdxss1
Zdxss1 May. 11 at 3:37 PM
$CMMB Investor communication is not about “culture” or optional style — it’s bound by legal disclosure requirements. Management must meet those obligations through filings, press releases, and earnings calls. Anything beyond that — frequent updates, promotional tone, or extra engagement — usually has a purpose: preparing the market for equity financing. When you see a company constantly communicating and promoting, it often signals that new shares are coming. That’s why I don’t view silence as inherently negative. If management is only meeting the legal minimum, it suggests they are not aiming to dilute shareholders through a stock offering. In that case, investors should actually be relieved: less noise often means no hidden agenda to flood the market with new equity. You should be happy😃
0 · Reply
dom3
dom3 May. 11 at 3:14 PM
$CMMB All comments stated below as to why the investment community remains skeptical are correct. However, the chart continues to scream bullish in spite of it all. We are now bidding in the 1.80 area and the short term continues to point higher. Are the tech indicators ahead of the skeptics? Only time will tell. The 2.00's are in site. Notice the bears saying less and less as they repeatedly said we would be at 1.20 by end of january...
0 · Reply
W2Cap
W2Cap May. 11 at 2:05 PM
$CMMB could easily become the next SRPB. Easy. But it's been over a year of them posting all this great data and information and posters... no partnership, no BTD, no steps forward whatsoever. We'll continue to gap down until they realise this.
1 · Reply
W2Cap
W2Cap May. 11 at 12:57 PM
$CMMB Come on... ''cultural differences'' 😄 They don't communicate with their investors because in their culture they don't communicate with their investors? Sorry but no, it's been a long time and the stock has slowly been bleeding. If you don't get a deal done and don't respect your investors - your stock gets killed.
2 · Reply